Natural Capsules Limited Announces EGM on Sep 9 to approve Preferential Issue
Natural Capsules Limited will hold an EGM on September 9, 2026, to approve a preferential issue. This includes up to 1,12,500 equity shares at ₹178 each and 450,000 warrants at ₹178 each. The revisions follow queries from stock exchanges and are based on a recent valuation report.
The preferential issue could lead to dilution for existing shareholders, but it also provides capital for the company's operations and potential expansion, hence a medium impact.
The announcement is positive as it pertains to a preferential issue which is a form of equity fundraising, aimed at strengthening the company's financial position and supporting growth initiatives.
Natural Capsules Limited has announced the completion of dispatch for the Corrigendum Notice of its Extraordinary General Meeting (EGM). The EGM is scheduled to be held on Wednesday, September 09, 2026, at 12:00 PM IST, through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
The Corrigendum to the EGM Notice has been issued to reflect revised pricing and quantity of Equity Shares and Convertible Warrants to be issued on a preferential basis to the Promoter Group. This revision follows queries raised by BSE & NSE and is based on a Valuation Report dated August 31, 2026. The preferential issue includes up to 1,12,500 Equity Shares at a revised issue price of ₹178 per share, and up to 450,000 Convertible Warrants at a revised issue price of ₹178 per warrant, with an upfront subscription amount of ₹44.50 per warrant.
The electronic dispatch of the Corrigendum Notice was completed on Wednesday, September 02, 2026. The original EGM Notice, along with the Corrigendum, is available on the company's website (www.naturalcapsules.com), the BSE and NSE websites, and the NSDL e-voting website.
The cut-off date for determining eligibility to vote was Wednesday, September 02, 2026. The remote e-voting period commenced on Friday, September 04, 2026, and concluded on Tuesday, September 08, 2026. Mr. Deepak Sadhu of Deepak Sadhu & Company has been appointed as the Scrutinizer.
What to do with a filing like this
Natural Capsules Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Natural Capsules Limited. Read the original for the full detail.